Chemically Structure (Image 01)
Fingolimod Capsule
Product Images NDC 43547-003
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 43547-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Image 02)
The text is presenting a graph or table showing the percentage of patients with three-month confirmed progression in a treatment group over a period of time, measured in days. The treatment group is likely receiving Fingolimod capsules at a dosage of 0.5 mg, and the numbers 30, 90, 180, 270, 360, 450, 540, 630, and 720 likely correspond to the time intervals being measured.*
0.5mg (Image 03)
Fingolimod capsules are a medication that contains 0.5 mg of fingolimod hydrochloride. The dosage is to be determined by the package insert. The capsules should be stored between 20°C to 26°C, with excursions up to 15°C to 30°C permitted. Protect from moisture. The manufacturer is Zhejiang Huahai Pharmaceutical Co. Ltd, and the distributor is Solo Healthcare US, LLC. For more information, contact Princeton Pharmaceutical Inc. at 1-866-257-2597. The medication guide should be dispensed to each patient.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
